Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0867
D

Failure to Implement Effective QAPI and Medication Reconciliation Processes

Taunton, Massachusetts Survey Completed on 05-13-2025

Penalty

Fine: $342,260
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that its Quality Assurance Committee developed and implemented an effective Performance Improvement Plan (PIP) to address quality deficiencies related to delayed laboratory result reporting, readmission medication reconciliation, and pharmacy Admission Medication Regimen Review (AMRR) after admission or readmission. The facility's QAPI policy required systematic monitoring and analysis of performance to improve resident outcomes, with specific benchmarks and input from staff, residents, and families. However, documentation and interviews revealed that these processes were not effectively followed in the case reviewed. A resident with a history of stroke, heart failure, and organ transplant was admitted to the facility and required close monitoring of tacrolimus levels as part of immunosuppressive therapy. Physician's orders specified regular lab draws and communication of results to the transplant team. After a hospital readmission, the resident's tacrolimus was discontinued in error, and there was a significant delay in obtaining and reporting lab results. The medical record did not show that the required AMRR was completed by the consultant pharmacist after the resident's return from the hospital. Additionally, the facility failed to communicate abnormal lab results to the transplant team in a timely manner, and the medication error was not promptly identified or addressed. Interviews with facility staff and external care providers indicated breakdowns in communication, lack of follow-through, and confusion regarding education provided to staff about medication reconciliation procedures. The Cardiology RN reported extensive difficulties in obtaining updated medication lists and lab results from the facility, and the facility's documentation did not reflect that the QAPI committee had identified or addressed all aspects of the deficiency, including missed lab draws, lack of AMRR, and communication failures. The PIP lacked established benchmarks or targets for monitoring performance improvement activities.

An unhandled error has occurred. Reload 🗙